Cellerix, TiGenix deal

Musculoskeletal company TiGenix will acquire Cellerix in a stock deal that values Cellerix at €58 million ($79.8 million). TiGenix will issue 44.8 million new TiGenix shares

Read the full 265 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE